Despite the Stigma, Hims & Hers Isn't Backing Away From Weight Loss Drugs
In spite of growing scrutiny around compounded versions of semaglutide medications, COO Melissa Baird says Hims…
In spite of growing scrutiny around compounded versions of semaglutide medications, COO Melissa Baird says Hims…
Boosted by an early investment from Sam Altman, 1910 Genetics recently struck a major partnership with…
The company’s new CEO admits its past approach to weight loss was flawed. But will embracing…